The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Netea, M. G.
Right arrow Articles by Van der Meer, J. W. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Netea, M. G.
Right arrow Articles by Van der Meer, J. W. M.
The Journal of Immunology, 1999, 162: 4876-4881.
Copyright © 1999 by The American Association of Immunologists

Soluble Murine IL-1 Receptor Type I Induces Release of Constitutive IL-1{alpha}1

Mihai G. Netea*, Bart Jan Kullberg*, Otto C. Boerman{dagger}, Ineke Verschueren*, Charles A. Dinarello{ddagger} and Jos W. M. Van der Meer2,*

* Division of General Internal Medicine, Department of Medicine and {dagger} Department of Nuclear Medicine, University Hospital Nijmegen, Nijmegen, The Netherlands; and {ddagger} Department of Medicine, Division of Infectious Diseases, University of Colorado Health Sciences Center, Denver, CO 80261

IL-1{alpha} and IL-1ß are proinflammatory cytokines involved in the pathogenesis of many infectious and noninfectious inflammatory diseases. To reduce IL-1 toxicity, extracellular domains of the soluble (s) IL-1R are shed from cell membranes and prevent triggering of cell-bound receptors. We investigated to what extent murine sIL-1RI can neutralize the IL-1 produced by LPS-stimulated macrophages. When mouse peritoneal macrophages were incubated with LPS, addition of sIL-1RI significantly inhibited the bioactivity of IL-1. Stimulation of cells with sIL-1RI alone induced no bioactive IL-1. When immunoreactive cytokine concentrations were measured with specific radioimmunoassays, sIL-1RI alone appeared to induce a significant release of IL-1{alpha} in a concentration-dependent manner. This effect was independent of new protein synthesis. The production of IL-1ß or TNF-{alpha} was not influenced by sIL-1RI. There was no interference of sIL-1RI with the IL-1{alpha} radioimmunoassay. In mice, an i.v. injection of sIL-RI alone induced a rapid release of IL-1{alpha}, but not of TNF-{alpha} or IL-1ß. Treatment of mice with sIL-1RI improved the survival during a lethal infection with Candida albicans. In conclusion, sIL-1RI induces a rapid release of IL-1{alpha} from cells, as well as into the systemic circulation. Although this IL-1{alpha} may be inactivated in circulation by the same sIL-1RI, this phenomenon probably has immunostimulatory effects at local levels where the sIL-1RI-induced IL-1{alpha} acts in a paracrine or autocrine manner.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1999 by The American Association of Immunologists, Inc. All rights reserved.